✳ GrantAtlasSign in ↗
← All opportunities

forecasted

Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge

Centers for Disease Control - NCBDDD · CDC-RFA-DD-27-0028

Award range

$0 – $0

Deadline

Not specified

Eligible applicants

Others (see text field entitled "Additional Information on Eligibility" for clarification), Public and State controlled institutions of higher education, Native American tribal organizations (other than Federally recognized tribal governments), Independent school districts, For profit organizations other than small businesses, Special district governments, State governments, Public housing authorities/Indian housing authorities, County governments, City or township governments, Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility", Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Native American tribal governments (Federally recognized), Small businesses

Geographic eligibility and all attachment-specific conditions require review of the original announcement.

Eligibility details

The NOFO has three components: Component A, Component B, and Component C. Eligible applicants may apply for only one component. If an applicant submits multiple applications, all applications submitted by that applicant will be deemed non-responsive, and will not receive further review. In the "Descriptive Title of Applicant's Project" on the SF-424 form, applicants must identify the component and, as applicable, the strategies for which they are applying. Applicants that do not identify the applicable components and strategies on the SF-424 form will be deemed non-responsive and will not receive further review. Eligible applicants for Component A must have the public health authority, legislative mandate or otherwise show legal access to the requisite data to conduct clinic-based surveillance. This authority or access must allow unique and specific access to datasets from multiple data sources that are required to implement the activities outlined in this NOFO. Eligible applicants must upload this documentation as a PDF to www.grants.gov under "Other Attachment Forms" using the attachment name "Legal Authority".CDC will consider any application that does not include this required documentation as non-responsive, and it will receive no further review. Eligible applicants for Component B must demonstrate their ability and capacity to identify and reach one or more target populations, which include people with FASDs, their families, and/or their communities, as well as clinical and public health professionals, who serve patients or clients who could be impacted by FASDs, across the United States. Applicants must also demonstrate their ability to develop new communication materials and continually identify and update resources that could be applied to one or more target populations, as well as quantify metrics of impact. Applicant's history of outreach to these populations should include, but may not be limited to, evidence-based educational information, resources, and support.Eligible applicants for Component C must be able to demonstrate ability to provide informatics and technical support to Component A applicants supporting standardized data collection, quality assurance, and timely data submission.

Matching funds & resources

Source matching-funds field: Not Required.

Matching funds and leveraged resources are different requirements. Read the description and reviewed rules below before determining resource commitments.

About this opportunity

CDC proposes to allocate funds to implement Notice of Funding Opportunity (NOFO) DD-27-0028, Maternal Child Surveillance and Partnerships for Action, Results, and Knowledge . This NOFO will integrate maternal child health surveillance with national partnership activities to address key public health challenges including alcohol use during pregnancy, fetal alcohol spectrum disorders (FASDs), neonatal abstinence syndrome (NAS), and cytomegalovirus (CMV). The NOFO will support entities with appropriate data authority and infrastructure to initiate, sustain, enhance, and/or expand clinical surveillance systems capturing data on pregnant women, infants, and/or children. Funding will prioritize improving data quality and enabling timely reporting and dissemination of evolving outcome data. Funded entities participating in clinical surveillance will monitor prenatal exposures such as alcohol use and polysubstance use during pregnancy as well as conditions with significant public health impact such as FASDs, NAS, congenital CMV, and other outcomes. CDC will also fund entities with informatics expertise to provide technical assistance to funded entities conducting clinical surveillance, improve data quality, and support dissemination of data through visualizations. Furthermore, this clinical surveillance network could be leveraged to address emerging, reemerging, and persistent public health threats to pregnant women and infants. In addition, this NOFO will invest in national partnership activities to prevent FASDs and improve early identification as well as support and care of affected infants and children. Activities may include serving as a national FASD resource; advancing evidence-based messaging; building clinical capacity through a holistic, lifespan approach; addressing regional, state, local, and/or tribal jurisdiction gaps; advancing coordination and translation of activities; and evaluating program strategies. Together, these activities establish a combined framework that emphasizes data to action approaches that translate high quality surveillance data into prevention strategies, pathways to referral and support, and improved outcomes.

Funding geography: Not specified — review source. A funder’s address does not establish eligibility.

Review original source ↗

Funding instrument: Cooperative Agreement. Issuing jurisdiction: Federal. This is not a geographic eligibility determination.

Source fields and evidence

id: 363313
Source ↗ · id

opportunityNumber: CDC-RFA-DD-27-0028
Source ↗ · opportunityNumber

opportunityTitle: Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge
Source ↗ · opportunityTitle

revision: 0
Source ↗ · revision

agencyDetails: {"code":"NCBDDD","seed":"HHS-CDC-NCBDDD","agencyName":"Centers for Disease Control - NCBDDD","agencyCode":"HHS-CDC-NCBDDD","topAgencyCode":"HHS"}
Source ↗ · agencyDetails

owningAgencyCode: HHS-CDC-NCBDDD
Source ↗ · owningAgencyCode

cfdas: [{"id":434711,"opportunityId":363313,"cfdaNumber":"93.073","programTitle":"Birth Defects and Developmental Disabilities - Prevention and Surveillance"}]
Source ↗ · cfdas

forecastDesc: <p>CDC proposes to allocate funds to implement Notice of Funding Opportunity (NOFO) DD-27-0028, <i>Maternal Child Surveillance and Partnerships for Action, Results, and Knowledge</i>. This NOFO will integrate maternal child health surveillance with national partnership activities to address key public health challenges including alcohol use during pregnancy, fetal alcohol spectrum disorders (FASDs), neonatal abstinence syndrome (NAS), and cytomegalovirus (CMV).&nbsp;</p><p>The NOFO will support entities with appropriate data authority and infrastructure to initiate, sustain, enhance, and/or expand clinical surveillance systems capturing data on pregnant women, infants, and/or children. Funding will prioritize improving data quality and enabling timely reporting and dissemination of evolving outcome data.</p><p>Funded entities participating in clinical surveillance will monitor prenatal exposures such as alcohol use and polysubstance use during pregnancy as well as conditions with significant public health impact such as FASDs, NAS, congenital CMV, and other outcomes. CDC will also fund entities with informatics expertise to provide technical assistance to funded entities conducting clinical surveillance, improve data quality, and support dissemination of data through visualizations. Furthermore, this clinical surveillance network could be leveraged to address emerging, reemerging, and persistent public health threats to pregnant women and infants.</p><p>In addition, this NOFO will invest in national partnership activities to prevent FASDs and improve early identification as well as support and care of affected infants and children. Activities may include serving as a national FASD resource; advancing evidence-based messaging; building clinical capacity through a holistic, lifespan approach; addressing regional, state, local, and/or tribal jurisdiction gaps; advancing coordination and translation of activities; and evaluating program strategies.&nbsp;</p><p>Together, these activities establish a combined framework that emphasizes data to action approaches that translate high quality surveillance data into prevention strategies, pathways to referral and support, and improved outcomes.</p>
Source ↗ · forecastDesc

applicantTypes: [{"id":"25","description":"Others (see text field entitled \"Additional Information on Eligibility\" for clarification)"},{"id":"06","description":"Public and State controlled institutions of higher education"},{"id":"11","description":"Native American tribal organizations (other than Federally recognized tribal governments)"},{"id":"05","description":"Independent school districts"},{"id":"22","description":"For profit organizations other than small businesses"},{"id":"04","description":"Special district governments"},{"id":"00","description":"State governments"},{"id":"08","description":"Public housing authorities/Indian housing authorities"},{"id":"01","description":"County governments"},{"id":"02","description":"City or township governments"},{"id":"99","description":"Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled \"Additional Information on Eligibility\""},{"id":"13","description":"Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education"},{"id":"20","description":"Private institutions of higher education"},{"id":"12","description":"Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education"},{"id":"07","description":"Native American tribal governments (Federally recognized)"},{"id":"23","description":"Small businesses"}]
Source ↗ · applicantTypes

applicantEligibilityDesc: The NOFO has three components: Component A, Component B, and Component C. Eligible applicants may apply for only one component. If an applicant submits multiple applications, all applications submitted by that applicant will be deemed non-responsive, and will not receive further review. In the &quot;Descriptive Title of Applicant's Project&quot; on the SF-424 form, applicants must identify the component and, as applicable, the strategies for which they are applying. Applicants that do not identify the applicable components and strategies on the SF-424 form will be deemed non-responsive and will not receive further review. Eligible applicants for Component A must have the public health authority, legislative mandate or otherwise show legal access to the requisite data to conduct clinic-based surveillance. This authority or access must allow unique and specific access to datasets from multiple data sources that are required to implement the activities outlined in this NOFO. Eligible applicants must upload this documentation as a PDF to www.grants.gov under &quot;Other Attachment Forms&quot; using the attachment name &quot;Legal Authority&quot;.CDC will consider any application that does not include this required documentation as non-responsive, and it will receive no further review. Eligible applicants for Component B must demonstrate their ability and capacity to identify and reach one or more target populations, which include people with FASDs, their families, and/or their communities, as well as clinical and public health professionals, who serve patients or clients who could be impacted by FASDs, across the United States. Applicants must also demonstrate their ability to develop new communication materials and continually identify and update resources that could be applied to one or more target populations, as well as quantify metrics of impact. Applicant's history of outreach to these populations should include, but may not be limited to, evidence-based educational information, resources, and support.Eligible applicants for Component C must be able to demonstrate ability to provide informatics and technical support to Component A applicants supporting standardized data collection, quality assurance, and timely data submission.
Source ↗ · applicantEligibilityDesc

fundingInstruments: [{"id":"CA","description":"Cooperative Agreement"}]
Source ↗ · fundingInstruments

fundingActivityCategories: [{"id":"HL","description":"Health"}]
Source ↗ · fundingActivityCategories

awardFloor: 0
Source ↗ · awardFloor

awardCeiling: 0
Source ↗ · awardCeiling

costSharing: false
Source ↗ · costSharing

lastUpdatedDate: Jul 24, 2026 04:51:21 PM EDT
Source ↗ · lastUpdatedDate

status: forecasted
Source ↗ · oppHits[id=363313].oppStatus

Source retrieved 10/15/2026 · Revision 0. Always confirm current requirements and dates with the funder. Structured source fields are checked; this is not a determination that every applicant qualifies.

Build your funding pipeline.

Save opportunities, filter by fit, and export your deadlines with membership.

View plans from $49/month ↗